Annual FCF
-$800.36 M
-$2.40 B-150.17%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual free cash flow is -$800.36 million, with the most recent change of -$2.40 billion (-150.17%) on December 31, 2023.
- During the last 3 years, VIR annual FCF has fallen by -$602.87 million (-305.27%).
- VIR annual FCF is now -150.17% below its all-time high of $1.60 billion, reached on December 31, 2022.
Performance
VIR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$173.84 M
-$95.32 M-121.41%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly free cash flow is -$173.84 million, with the most recent change of -$95.32 million (-121.41%) on September 30, 2024.
- Over the past year, VIR quarterly FCF has dropped by -$95.32 million (-121.41%).
- VIR quarterly FCF is now -118.50% below its all-time high of $939.54 million, reached on June 30, 2022.
Performance
VIR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$473.07 M
-$14.29 M-3.12%
September 30, 2024
Summary
- As of February 7, 2025, VIR TTM free cash flow is -$473.07 million, with the most recent change of -$14.29 million (-3.12%) on September 30, 2024.
- Over the past year, VIR TTM FCF has dropped by -$14.29 million (-3.12%).
- VIR TTM FCF is now -129.66% below its all-time high of $1.60 billion, reached on December 31, 2022.
Performance
VIR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VIR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -150.2% | -121.4% | -3.1% |
| 3 y3 years | -305.3% | -31.1% | -151.0% |
| 5 y5 years | -682.5% | -31.1% | -151.0% |
VIR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -150.2% | at low | -118.5% | +56.4% | -129.7% | +40.9% |
| 5 y | 5-year | -150.2% | at low | -118.5% | +56.4% | -129.7% | +40.9% |
| alltime | all time | -150.2% | at low | -118.5% | +56.4% | -129.7% | +40.9% |
Vir Biotechnology Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$173.84 M(+121.4%) | -$473.07 M(+3.1%) |
| Jun 2024 | - | -$78.51 M(-29.4%) | -$458.78 M(-41.1%) |
| Mar 2024 | - | -$111.26 M(+1.6%) | -$778.97 M(-2.7%) |
| Dec 2023 | -$800.36 M(-150.2%) | -$109.46 M(-31.4%) | -$800.36 M(+19.8%) |
| Sep 2023 | - | -$159.54 M(-60.0%) | -$668.34 M(+63.1%) |
| Jun 2023 | - | -$398.70 M(+200.6%) | -$409.89 M(-144.2%) |
| Mar 2023 | - | -$132.65 M(-688.2%) | $928.35 M(-41.8%) |
| Dec 2022 | $1.60 B(-2398.4%) | $22.55 M(-77.2%) | $1.60 B(+1.8%) |
| Sep 2022 | - | $98.91 M(-89.5%) | $1.57 B(+15.5%) |
| Jun 2022 | - | $939.54 M(+75.9%) | $1.36 B(+144.4%) |
| Mar 2022 | - | $534.25 M(<-9900.0%) | $555.04 M(-899.7%) |
| Dec 2021 | -$69.41 M | -$5.37 M(-95.2%) | -$69.41 M(-53.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$111.82 M(-181.0%) | -$148.52 M(+68.7%) |
| Jun 2021 | - | $137.98 M(-253.0%) | -$88.01 M(-63.0%) |
| Mar 2021 | - | -$90.20 M(+6.8%) | -$237.97 M(+20.5%) |
| Dec 2020 | -$197.49 M(+42.5%) | -$84.48 M(+64.6%) | -$197.49 M(+28.7%) |
| Sep 2020 | - | -$51.31 M(+328.3%) | -$153.44 M(+9.3%) |
| Jun 2020 | - | -$11.98 M(-75.9%) | -$140.34 M(-9.6%) |
| Mar 2020 | - | -$49.71 M(+22.9%) | -$155.32 M(+12.1%) |
| Dec 2019 | -$138.57 M(+35.5%) | -$40.44 M(+5.8%) | -$138.57 M(+41.2%) |
| Sep 2019 | - | -$38.21 M(+41.7%) | -$98.14 M(+63.8%) |
| Jun 2019 | - | -$26.96 M(-18.2%) | -$59.92 M(+81.8%) |
| Mar 2019 | - | -$32.97 M | -$32.97 M |
| Dec 2018 | -$102.29 M(+48.0%) | - | - |
| Dec 2017 | -$69.12 M | - | - |
FAQ
- What is Vir Biotechnology annual free cash flow?
- What is the all time high annual FCF for Vir Biotechnology?
- What is Vir Biotechnology annual FCF year-on-year change?
- What is Vir Biotechnology quarterly free cash flow?
- What is the all time high quarterly FCF for Vir Biotechnology?
- What is Vir Biotechnology quarterly FCF year-on-year change?
- What is Vir Biotechnology TTM free cash flow?
- What is the all time high TTM FCF for Vir Biotechnology?
- What is Vir Biotechnology TTM FCF year-on-year change?
What is Vir Biotechnology annual free cash flow?
The current annual FCF of VIR is -$800.36 M
What is the all time high annual FCF for Vir Biotechnology?
Vir Biotechnology all-time high annual free cash flow is $1.60 B
What is Vir Biotechnology annual FCF year-on-year change?
Over the past year, VIR annual free cash flow has changed by -$2.40 B (-150.17%)
What is Vir Biotechnology quarterly free cash flow?
The current quarterly FCF of VIR is -$173.84 M
What is the all time high quarterly FCF for Vir Biotechnology?
Vir Biotechnology all-time high quarterly free cash flow is $939.54 M
What is Vir Biotechnology quarterly FCF year-on-year change?
Over the past year, VIR quarterly free cash flow has changed by -$95.32 M (-121.41%)
What is Vir Biotechnology TTM free cash flow?
The current TTM FCF of VIR is -$473.07 M
What is the all time high TTM FCF for Vir Biotechnology?
Vir Biotechnology all-time high TTM free cash flow is $1.60 B
What is Vir Biotechnology TTM FCF year-on-year change?
Over the past year, VIR TTM free cash flow has changed by -$14.29 M (-3.12%)